J&J puts the brakes on immunotherapy combination studies – MedCity News
MedCity NewsJ&J puts the brakes on immunotherapy combination studiesMedCity NewsThe maker of a drug approved to treat the blood cancer multiple myeloma has stopped a clinical trial combining it with an immunotherapy agent in lung cancer and stopped… Continue reading
